BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 20 September 2006. doi:10.1136/bjo.2006.100925
British Journal of Ophthalmology 2007;91:233-236
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
bjo.2006.100925v1
91/2/233    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scherrer, J.
Right arrow Articles by Garweg, J. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scherrer, J.
Right arrow Articles by Garweg, J. G

SCIENTIFIC REPORT

Visual function in human ocular toxoplasmosis

Janine Scherrer1,*, Milko E Iliev1,*, Markus Halberstadt3, Laurent Kodjikian4, Justus G Garweg2

1 Department of Ophthalmology, University of Bern, Bern, Switzerland
2 Swiss Eye Institute, Bern, Switzerland
3 Department of Ophthalmology, Med University, Hannover, Germany
4 Department of Ophthalmology, Croix-Rousse Hospital, University of Lyon I Claude Bernard, Lyon, France

Correspondence to:
Correspondence to:
Dr J G Garweg
Swiss Eye Institute, Bremgartenstr 119, CH-3012 Bern, Switzerland; justus.garweg{at}eye-institute.ch


ABSTRACT
Aim: To assess functional impairment in terms of visual acuity reduction and visual field defects in inactive ocular toxoplasmosis.

Methods: 61 patients with known ocular toxoplasmosis in a quiescent state were included in this prospective, cross-sectional study. A complete ophthalmic examination, retinal photodocumentation and standard automated perimetry (Octopus perimeter, program G2) were performed. Visual acuity was classified on the basis of the World Health Organization definition of visual impairment and blindness: normal (>=20/25), mild (20/25 to 20/60), moderate (20/60 to 20/400) and severe (<20/400). Visual field damage was correspondingly graded as mild (mean defect <4 dB), moderate (mean defect 4–12 dB) or severe (mean defect >12 dB).

Results: 8 (13%) patients presented with bilateral ocular toxoplasmosis. Thus, a total of 69 eyes was evaluated. Visual field damage was encountered in 65 (94%) eyes, whereas only 28 (41%) eyes had reduced visual acuity, showing perimetric findings to be more sensitive in detecting chorioretinal damage (p<0.001). Correlation with the clinical localisation of chorioretinal scars was better for visual field (in 70% of the instances) than for visual acuity (33%). Moderate to severe functional impairment was registered in 65.2% for visual field, and in 27.5% for visual acuity.

Conclusion: In its quiescent stage, ocular toxoplasmosis was associated with permanent visual field defects in >94% of the eyes studied. Hence, standard automated perimetry may better reflect the functional damage encountered by ocular toxoplasmosis than visual acuity.


Abbreviations: BCVA, best-corrected visual acuity; WHO, World Health Organization







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.